NUCLEOPHOSMIN IN ACUTE MYELOGENOUS LEUKEMIA AND ITS PROGNOSTIC IMPACT
Marwa Saeed Mouselhy;
Abstract
Acute myeloid leukemia (AML) is clinically, cytogenetically, and molecularly heterogeneous. About 30% of cases carry recurrent chromosomal abnormalities that identify leukemia entities with distinct clinical and prognostic features, and 10% to 15% of AMLs
Other data
| Title | NUCLEOPHOSMIN IN ACUTE MYELOGENOUS LEUKEMIA AND ITS PROGNOSTIC IMPACT | Authors | Marwa Saeed Mouselhy | Keywords | NUCLEOPHOSMIN IN ACUTE MYELOGENOUS LEUKEMIA AND ITS PROGNOSTIC IMPACT | Issue Date | 2009 | Description | Acute myeloid leukemia (AML) is clinically, cytogenetically, and molecularly heterogeneous. About 30% of cases carry recurrent chromosomal abnormalities that identify leukemia entities with distinct clinical and prognostic features, and 10% to 15% of AMLs |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.